Eubiologics Venture Capital
3 known investors
Find your way into Eubiologics Venture Capital
Sign up to see every warm intro you have to Eubiologics Venture Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eubiologics Venture Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EuBiologics is a South Korean vaccine company that develops and manufactures preventive and next-generation vaccines, including oral cholera and typhoid conjugate vaccines, with WHO prequalification for global public health supply. It also offers CRMO services covering research, process development, GMP manufacturing, and quality for client vaccine programs.
Investors · 3
Frequently asked questions
- What does Eubiologics Venture Capital do?
- EuBiologics is a South Korean vaccine company that develops and manufactures preventive and next-generation vaccines, including oral cholera and typhoid conjugate vaccines, with WHO prequalification for global public health supply. It also offers CRMO services covering research, process development, GMP manufacturing, and quality for client vaccine programs.
- Who are Eubiologics Venture Capital's investors?
- Eubiologics Venture Capital's investors include Aju IB Investment, IMM Investment Japan, SBI Investment Korea Co. Ltd..